| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |